Moderna and Mitsubishi Tanabe Pharma agreed to endorse Moderna’s respiratory vaccine portfolio in Japan. The US has awarded Moderna $176 million to develop an mRNA pandemic flu vaccine. Moderna's combined COVID-flu vaccine has passed a significant test. Concurrently, Federal Funds are being allocated for mRNA bird flu vaccine as pandemic fears escalate. Still, Moderna's RSV vaccine yielded lower-than-expected results, triggering a decrease in stock value. There's news concerning Moderna readying for a potential RSV vaccine rollout in the fall following encouraging Q1 results. Initial data from a rare-disease trial highlight Moderna's efforts to evolve mRNA into medicines. Blackstone Life Sciences is supporting Moderna’s Influenza program amidst the spreading H5N1. A multi-million dollar agreement has been made for Moderna's influenza vaccine development. However, the creation of a manufacturing plant in Kenya was suspended due to uncertain vaccine demand. The FDA recently approved Moderna's RSV vaccine for older adults. Despite this, there's a lot of anticipation surrounding Moderna’s combined covid-flu vaccine.
Moderna MRNA News Analytics from Tue, 12 Sep 2023 07:00:00 GMT to Sun, 14 Jul 2024 10:20:34 GMT -
Rating -1
- Innovation 5
- Information 7
- Rumor -7
